A resolution expressing support for the designation of September 2024 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

Bill 118 sres 861 is a resolution that aims to designate September 2024 as "Sickle Cell Disease Awareness Month" in the United States. The purpose of this designation is to educate communities about sickle cell disease and the importance of research, early detection methods, effective treatments, and preventative care programs for individuals affected by the disease.

Sickle cell disease is a genetic blood disorder that affects red blood cells, causing them to become rigid and sickle-shaped. This can lead to various complications, including pain, organ damage, and an increased risk of infections. It primarily affects African Americans, but can also impact individuals of Hispanic, Mediterranean, and Middle Eastern descent.

The resolution emphasizes the need for increased awareness and understanding of sickle cell disease in order to improve the quality of life for those living with the condition. It also highlights the importance of funding research efforts to develop better treatments and ultimately find a cure for the disease. By designating September 2024 as "Sickle Cell Disease Awareness Month," the resolution aims to bring attention to this often overlooked health issue and encourage communities to support individuals affected by sickle cell disease. It underscores the importance of early detection, effective treatments, and preventative care programs to help manage the complications associated with the disease. Overall, Bill 118 sres 861 seeks to raise awareness about sickle cell disease and promote efforts to improve the lives of those impacted by this genetic blood disorder.